-
Product Insights
Benban ARC Solar PV Park
Benban ARC Solar PV Park is a solar PV project located in Aswan, Egypt. The project is owned by Globeleq Africa Ltd and was developed by Desert Technologies; Enerray SPA; SECI Energia SpA. The project came online in 2019. Empower your strategies with our Benban ARC Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Thematic Analysis
NewApparel M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Apparel Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACLX-002 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACLX-002 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACLX-002 in Myelodysplastic Syndrome Drug Details: ACLX-002 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACLX-002 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACLX-002 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACLX-002 in Refractory Acute Myeloid Leukemia Drug Details: ACLX-002 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACLX-002 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACLX-002 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACLX-002 in Relapsed Acute Myeloid Leukemia Drug Details: ACLX-002 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anitocabtagene Autoleucel in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anitocabtagene Autoleucel in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anitocabtagene Autoleucel in Relapsed Multiple Myeloma Drug Details: Anitocabtagene autoleucel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anitocabtagene Autoleucel in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anitocabtagene Autoleucel in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anitocabtagene Autoleucel in Refractory Multiple Myeloma Drug Details: Anitocabtagene autoleucel...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TPI-287 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TPI-287 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TPI-287 in Breast Cancer Drug Details: ARC-100 (TPI 287) is under development...
-
Company Insights
Innovation and Patenting activity of ARC Resources Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ARC Resources Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Arcs Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Arcs Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...